Cargando…

LMP1 and LMP2A are potential prognostic markers of extranodal NK/T-cell lymphoma, nasal type (ENKTL)

BACKGROUND: Latent membrane protein (LMP) 1 and LMP2A encoded by Epstein-Barr virus (EBV) are associated with the development of malignancies, but their expression in extranodal NK/T-cell lymphoma, nasal type (ENKTL) and the relationship with clinical characteristics of this disease remain poorly un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Yuan, Zhang, Da-Wei, Zhu, Huijun, Lin, Hong, Xiong, Lin, Cao, Qing, Liu, Ying, Li, Qing-Dong, Xu, Jia-Ren, Xu, Lin-Feng, Chen, Ren-Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539909/ https://www.ncbi.nlm.nih.gov/pubmed/23237707 http://dx.doi.org/10.1186/1746-1596-7-178

Ejemplares similares

Specific Soft-Tissue Invasion and LMP1 Expression Are Potential Indicators of Extranodal NK/T Cell Lymphoma, Nasal Type
por: Jiang, Min, et al.
Publicado: (2018)

A neutralized human LMP1-IgG inhibits ENKTL growth by suppressing the JAK3/STAT3 signaling pathway
por: Mao, Yuan, et al.
Publicado: (2016)

Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs
por: Cho, Seok-Goo, et al.
Publicado: (2015)

Primary pulmonary extranodal natural killer/T-cell lymphoma (ENKTL), nasal type: Two case reports and literature review
por: Hu, Qun, et al.
Publicado: (2020)

Co-Inhibition of the Immunoproteasome Subunits LMP2 and LMP7 Ameliorates Immune Thrombocytopenia
por: Du, Sheng-hong, et al.
Publicado: (2021)

Transcriptome Changes Induced by Epstein-Barr Virus LMP1 and LMP2A in Transgenic Lymphocytes and Lymphoma
por: Shair, Kathy H. Y., et al.
Publicado: (2012)

Educational Case: Extranodal NK/T-Cell Lymphoma, Nasal Type
por: Jia, Yue, et al.
Publicado: (2019)

Upregulation of MiR-155 in Nasopharyngeal Carcinoma is Partly Driven by LMP1 and LMP2A and Downregulates a Negative Prognostic Marker JMJD1A
por: Du, Zi-Ming, et al.
Publicado: (2011)

Epstein-Barr Virus BART9 miRNA Modulates LMP1 Levels and Affects Growth Rate of Nasal NK T Cell Lymphomas
por: Ramakrishnan, Rajesh, et al.
Publicado: (2011)

Immunohistochemical Identification and Assessment of the Location of Immunoproteasome Subunits LMP2 and LMP7 in Acquired Cholesteatoma
por: Rutkowska, Justyna, et al.
Publicado: (2023)

The Anti-Apoptotic Role of EBV-LMP1 in Lymphoma Cells
por: Zeng, Mei, et al.
Publicado: (2020)

Therapeutic vaccine targeting Epstein-Barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo
por: Lin, Mei-Chun, et al.
Publicado: (2017)

Characterization of human Fab antibody fragments specific to LMP1 (HLEAFab) in nasopharyngeal carcinoma for potential molecular diagnosis and therapeutic applications
por: ZHANG, DAWEI, et al.
Publicado: (2013)

The Immunoproteasome Subunits LMP2, LMP7 and MECL-1 Are Crucial Along the Induction of Cerebral Toxoplasmosis
por: French, Timothy, et al.
Publicado: (2021)

Granulysin, a novel marker for extranodal NK/T cell lymphoma, nasal type
por: Lo Bello, Giuseppe, et al.
Publicado: (2018)

Constructing Machine Tool Foundations Using an LMP Alloy
por: Zhang, Yi, et al.
Publicado: (2020)

The genetic association between LMP2 and LMP7 polymorphisms and susceptibility of insulin dependent diabetes mellitus: A meta-analysis
por: Xu, Yang, et al.
Publicado: (2020)

Two young patients with extranodal natural killer/T-cell non-Hodgkin lymphoma, nasal-type (ENKTL-NT) masquerading inflammatory processes: A case series
por: Anggraini, Neni, et al.
Publicado: (2021)

The association between the genetic polymorphisms of LMP2/LMP7 and the outcomes of HCV infection among drug users()
por: Cui, Qian, et al.
Publicado: (2010)

P1131: SERUM TRIGLYCERIDE AND APOLIPOPROTEIN A1 AS BIOMARKERS FOR EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA (ENKTL): A MULTICENTER STUDY
por: Cai, Qingqing, et al.
Publicado: (2023)

CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma
por: Li, Hongwen, et al.
Publicado: (2023)

Nasal-type extranodal T-cell/NK lymphoma in association with hemophagocytic syndrome
por: Guedes, Juliana Chaves Ruiz, et al.
Publicado: (2018)

Generation and Characterization of a Novel Recombinant Antibody against LMP1-TES1 of Epstein-Barr Virus Isolated by Phage Display
por: Zhang, Dawei, et al.
Publicado: (2013)

Extranodal NK/T-cell lymphoma, nasal type without evidence of EBV infection
por: Wang, Wei, et al.
Publicado: (2020)

Molecular Screening of Nasopharyngeal Carcinoma: Detection of LMP-1, LMP-2 Gene Expression in Vietnamese Nasopharyngeal Swab Samples
por: Lao, Thuan Duc, et al.
Publicado: (2019)

Multifocal primary cutaneous extranodal NK/T lymphoma nasal type
por: de Vasconcelos, Pedro, et al.
Publicado: (2016)

Evaluation of different staging systems and prognostic analysis of nasal-type extranodal NK/T-cell lymphoma based on consistent LVDP chemotherapy regimen
por: Wu, Wanchun, et al.
Publicado: (2022)

Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma
por: Kamara, Saidu, et al.
Publicado: (2023)

In vivo and in vitro study of co-expression of LMP1 and Cripto-1 in nasopharyngeal carcinoma()
por: Ye, Qing, et al.
Publicado: (2019)

Association of LMP/TAP Gene Polymorphisms with Tuberculosis Susceptibility in Li Population in China
por: Wang, Danmei, et al.
Publicado: (2012)

Characteristics and Clinical Implications of the Nasal Microbiota in Extranodal NK/T-Cell Lymphoma, Nasal Type
por: Shi, Zhuangzhuang, et al.
Publicado: (2021)

Extranodal nasal-type NK/T-cell lymphoma of the palate and paranasal sinuses
por: Nikolaos, Nikitakis, et al.
Publicado: (2012)

Extranodal NK/T-cell lymphoma, nasal type with extensive cardiopulmonary involvement
por: Marques-Piubelli, Mario L., et al.
Publicado: (2021)

Clinical and otorhinolaryngological aspects of extranodal NK/T cell lymphoma, nasal type()()
por: Miyake, Marcel Menon, et al.
Publicado: (2014)

Generating CTLs against the subdominant EBV LMP antigens by transit expression of an A20 inhibitor with EBV LMP proteins in human DCs
por: Hong, Bangxing, et al.
Publicado: (2011)

Constructing TC-1-GLUC-LMP2 Model Tumor Cells to Evaluate the Anti-Tumor Effects of LMP2-Related Vaccines
por: Sun, Liying, et al.
Publicado: (2018)

Genetic variability in LMP2 and LMP7 is associated with the risk of esophageal squamous cell carcinoma in the Kazakh population but is not associated with HPV infection
por: Yang, Lan, et al.
Publicado: (2017)

A Novel LMP1 Antibody Synergizes with Mitomycin C to Inhibit Nasopharyngeal Carcinoma Growth in Vivo Through Inducing Apoptosis and Downregulating Vascular Endothelial Growth Factor
por: Mao, Yuan, et al.
Publicado: (2012)

Clinical characteristics of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis
por: Liu, Yi-Zhen, et al.
Publicado: (2019)

The Role of Epstein-Barr Virus LMP-1 Immunohistochemical Staining in Childhood Hodgkin Lymphoma
por: Tanyildiz, Hikmet Gulsah, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bdn8m2kch1d6666jqfncmatsef